S. Locarnini
Publications by Year
Research Areas
Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment, Hepatitis Viruses Studies and Epidemiology
Most-Cited Works
- → Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B(2010)174 cited
- → Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation(1997)146 cited
- → Hepatitis B Virus Mutants and Fulminant Hepatitis B: Fitness Plus Phenotype(2001)54 cited
- → Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)(2003)41 cited
- → Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells(2004)27 cited
- → Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid(1995)26 cited
- → Demonstration of Duck Hepatitis B Virus in Bile Duct Epithelial Cells: Implications for Pathogenesis and Persistent Infection(1997)24 cited
- → Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial(2018)15 cited
- → Treatment of Chronically HBV-Infected Chimpanzees with RNA Interference Therapeutic ARC-520 LED to Potent Reduction of Viral MRNA, DNA and Proteins without Observed Drug Resistance(2016)11 cited
- → Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B(2018)9 cited